Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Generic version of indapamide approved in U.S.

June 21, 1996

Roussel Uclaf discloses endothelin antagonists

June 21, 1996

Endothelin antagonist claimed by Roche

June 21, 1996

U.K. restriction of sotalol hydrochloride

June 14, 1996

Antiarrhythmic agents from Merck & Co.

June 14, 1996

ITMR system phase II trial expansion granted

June 14, 1996

Selective PDGF inhibitors revealed

June 14, 1996

More Na+/H+-exchange inhibitors from E. Merck

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...